Detalhe da pesquisa
1.
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
BMC Infect Dis
; 22(1): 94, 2022 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086481
2.
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Lancet
; 393(10179): 1453-1464, 2019 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765123
3.
Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis: A Preliminary Study.
J Clin Gastroenterol
; 53(3): 236-241, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30383568
4.
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort.
BMC Infect Dis
; 19(1): 300, 2019 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30940090
5.
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients.
J Hepatol
; 66(1): 39-47, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622858
6.
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.
Clin Res Hepatol Gastroenterol
; 45(5): 101713, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33930591